NORE1A loss promotes MASLD/MASH
Transgenic Research · 2024
DOI: 10.1007/s11248-024-00407-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transgenic Research, 2024. Verfasst von Howard Donninger und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Louisville, Louisville, KY, USA. Hauptthemen laut MEDLINE: Mice, Knockout. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, CCR NIH HHS, Center for Cancer Research.
Abstract (Originalsprache)
NORE1A (RASSF5) is a tumor suppressor that is frequently down-regulated in liver tumors. It is an upstream component of the HIPPO pathway, a key regulator of liver development and metabolism. HIPPO disruption can lead to the development of MASLD/MASH. While studying the phenotype of NORE1A knockout mice, we noticed that they exhibit no overt liver tumor phenotype, but have a strong propensity to develop fatty livers characteristic of MASLD/MASH. Additionally, knockdown of NORE1A in liver cells upregulates sterol regulator element binding protein 1 (SREBP1), whose deregulation is central to the development MASLD. Examination of primary human MASLD samples showed an inverse correlation between the expression of NORE1A protein and TAZ, a downstream effector of the HIPPO pathway. Thus, loss of NORE1A expression may contribute to the development of MASLD/MASH in humans and NORE1A knockout mice may provide a new MASLD/MASH model that more accurately mimics the human disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Louisville, Louisville, KY, USA.
- Deptartment of Pharmacology, University of Cincinnati, Cincinnati, USA.
- Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA, USA.
- Department of Pharmacology & Toxicology, University of Louisville, Geoffrey J Clark, 417, CTRB, 505 S. Hancock St., Louisville, KY, 40202, USA. Gjclar01@louisville.edu.
Förderung
- NIDDK NIH HHS
- CCR NIH HHS
- Center for Cancer Research
Zitieren
APA
Donninger, H., Hobbing, K., Arteel, G. E., & Clark, G. J. (2024). NORE1A loss promotes MASLD/MASH. Transgenic Research. https://doi.org/10.1007/s11248-024-00407-8
Vancouver
Donninger H, Hobbing K, Arteel GE, Clark GJ. NORE1A loss promotes MASLD/MASH. Transgenic Research. 2024. doi:10.1007/s11248-024-00407-8
BibTeX
@article{Donninger2024,
author = {Donninger, Howard and Hobbing, Katherine and Arteel, Gavin E and Clark, Geoffrey J},
title = {NORE1A loss promotes MASLD/MASH},
journal = {Transgenic Research},
year = {2024},
doi = {10.1007/s11248-024-00407-8}
}
EUVIMED